In vivo studies evaluate whether such interactions impact drug exposure in humans

e and repressing a Th1 response, and that elevated levels of F. nucleatum detected in PD-sites are a result of the organism taking advantage of a permissive environment, and are not due to F. nucleatum-driven inflammation. SerpinE1, also known as PAI-1, is involved in resolution of inflammation, in particular by promoting macrophage migration away from sites of inflammation. PAI-1-deficient C57BL/6 mice experience more severe Gram-negative bacterial pneumonia than transgenic mice overexpressing PAI-1, evidenced by greater bacterial growth and dissemination, which suggests that in this mouse strain SerpinE1 is important for clearing bacterial infection. In F. nucleatum-infected mice, serpinE1 expression was elevated, which corresponded with the F4/80+ macrophage cell counts in aortic tissues at 24 weeks of infection. Fewer F4/80+ 15 / 19 F. nucleatum Repression of Inflammation in ApoEnull Mice macrophages were detected in the intimal layer of 24-week-infected mice than 12-weekinfected mice, indicating reduction of inflammation in the intimal layer, while greater numbers of F4/80+ macrophages were detected in the medial tissues than intimal tissues at 24 weeks. Together these observations suggest that the macrophages are migrating out of the aortic tissues towards the draining lymph nodes. The expression of serpinE1 was not affected in P. gingivalisinfected mice, which experienced an increase in F4/80+ macrophages at 24 weeks relative to 12 weeks, but not among 24 week-infected and control mice. T. denticola-infected mice experienced elevated aortic expression of serpinE1, yet no aortic tissue F4/80+ staining PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19705642 observed. However, fibrinogen gene expression at 24 weeks in T. denticola-infected mice is less strongly down-regulated than in F. nucleatum- or P. gingivalis-infected mice, which may indicate greater fibrin deposition in T. denticola-infected aortic tissue, which may promote macrophage retention. Several studies have examined the synergism between F. nucleatum and other bacterial pathogens in vitro and in rodent infection models, and have found that the inclusion of F. nucleatum results in greater pathogenic effects. In this PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19704080 regard and as suggested by our data, F. nucleatum may not act to promote atherogenesis alone, but may synergistically assist other organisms, particularly by disrupting cell-cell junctions, compromising the integrity of the endothelium, and enabling invasion. For example, F. nucleatum may prime the host to infection by other organisms, as is observed with Influenza A facilitating pneumococcal infection by damaging tissues, compromising local immunity and/or providing nutrition. Despite the recorded ability of F. nucleatum to induce endothelial cell dysfunction, chronic oral F. nucleatum infection did not alter the levels of serum NO, which is a potent indicator of vascular endothelial cell dysfunction. It may be concluded from the observations in our study that due to the interdependence of periodontal bacteria, no single periodontal bacterial species alone will effectively induce aortic disease pathology, rather it may be induced by a polymicrobial consortium. ~~ ~~ Medication LY-411575 co-administration can alter the pharmacokinetic or pharmacodynamic profiles of the drugs being prescribed. Drug-Drug Interactions occur when the effect of one drug is altered by the co-administration of another drug. This change in the effect can lead to the development of clinically important adverse events. In fact, a significant amount